Oct 10 (Reuters) - The U.S. Food and Drug Administration on Friday approved labeling changes for Johnson & Johnson (JNJ.N), opens new tab and its partner Legend Biotech's (LEGN.O), opens new tab blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback